These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 1362189

  • 21. A comparison study of lipid and androgen metabolism with triphasic oral contraceptive formulations containing norgestimate or levonorgestrel.
    Janaud A, Rouffy J, Upmalis D, Dain MP.
    Acta Obstet Gynecol Scand Suppl; 1992; 156():33-8. PubMed ID: 1324555
    [Abstract] [Full Text] [Related]

  • 22. [Metabolic risks of oral contraception].
    Monier L.
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [Abstract] [Full Text] [Related]

  • 23. Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives.
    Anderson FD.
    Acta Obstet Gynecol Scand Suppl; 1992 Feb; 156():15-21. PubMed ID: 1324552
    [Abstract] [Full Text] [Related]

  • 24. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK, Maina FW, Kigondu C, Mati JK.
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The androgenicity of oral contraceptives: the young patient's concerns.
    Runnebaum B.
    Int J Fertil; 1992 Aug; 37 Suppl 4():211-7. PubMed ID: 1362188
    [Abstract] [Full Text] [Related]

  • 28. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC.
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [Abstract] [Full Text] [Related]

  • 32. Experience with a new low dose oral contraceptive: norgestimate & ethinyl estradiol.
    Rubio-Lotvin B, Gonzales-Ansorena R.
    Acta Eur Fertil; 1978 Mar; 9(1):1-6. PubMed ID: 696184
    [Abstract] [Full Text] [Related]

  • 33. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 34. Norgestimate: a clinical overview of a new progestin.
    Bringer J.
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1969-77. PubMed ID: 1605287
    [Abstract] [Full Text] [Related]

  • 35. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG.
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [Abstract] [Full Text] [Related]

  • 36. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 37. [Combined estrogen-progestagen contraception and glucid and water-sodium metabolism].
    Belaisch J, Hommais-loufrani B.
    Contracept Fertil Sex (Paris); 1988 Feb; 16(2):3-7. PubMed ID: 12342001
    [Abstract] [Full Text] [Related]

  • 38. Update on the metabolic effects of steroidal contraceptives.
    Sondheimer SJ.
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):911-23. PubMed ID: 1778182
    [Abstract] [Full Text] [Related]

  • 39. [Oral contraceptives and metabolic changes].
    Lara Ricalde R, Aznar Ramos R.
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [Abstract] [Full Text] [Related]

  • 40. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.